June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) :
- US FDA AWARDS ORPHAN DRUG DESIGNATION (ODD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
June 17 (Reuters) - Kazia Therapeutics Ltd (KZA) : US FDA...
Add to My Watchlist
What is My Watchlist?